Role of Probiotics in Pediatric Patients with <i>Helicobacter pylori</i> Infection: A Comprehensive Review of the Literature
Abstract Background: The current guidelines suggest the use of triple therapy as first choice treatment of Helicobacter pylori infection, although the eradication failure rate is more than 30%. Current interest in probiotics as therapeutic agents against H. pylori is stimulated not only by the clini...
I tiakina i:
Ngā kaituhi matua: | Elena Lionetti, Flavia Indrio, Piero Pavone, Giorgia Borrelli, Luciano Cavallo, Ruggiero Francavilla |
---|---|
Hōputu: | Revisão |
Reo: | Ingarihi |
I whakaputaina: |
2010
|
Urunga tuihono: | https://doi.org/10.1111/j.1523-5378.2009.00743.x https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1523-5378.2009.00743.x |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
-
Randomised clinical trial: <i><scp>L</scp>actobacillus reuteri </i><scp>DSM</scp> 17938 vs. placebo in children with acute diarrhoea ‐ a double‐blind study
mā: Ruggiero Francavilla, me ētahi atu.
I whakaputaina: (2012) -
Use of probiotics in the fight against<i>Helicobacter pylori</i>
mā: Paolo Ruggiero
I whakaputaina: (2014) -
Limosilactobacillus reuteri Strains as Adjuvants in the Management of Helicobacter pylori Infection
mā: Dargenio, Costantino, me ētahi atu.
I whakaputaina: (2021) -
Probiotics in Celiac Disease
mā: Cristofori, Fernanda, me ētahi atu.
I whakaputaina: (2018) -
Probiotics in Celiac Disease
mā: Fernanda Cristofori, me ētahi atu.
I whakaputaina: (2018)